News
In Memoriam: George Teeling Smith, OHE’s First Director
17 February 2013
Professor George Teeling Smith OBE, who set up the Office of Health Economics in 1962 and served as its Director for three decades, died unexpectedly on…
Spotlight on OHE: Understanding Value Based Pricing
12 February 2013
Value based pricing (VBP) is increasingly common in health care systems worldwide. OHE continues to make important contributions to the debate about VBP approaches and application…
New Research: Achieving Efficient Prices for Drugs in a Global Context
7 February 2013
With Prof Patricia Danzon of the Wharton School, University of Pennsylvania, OHE’s Adrian Towse and Jorge Mestre-Ferrandiz have released an important working paper that addresses how…
EQ-5D Index Clustering: Causes and Implications for Health Care
5 February 2013
In a paper presented at the January 2013 Health Economics Study Group meeting, David Parkin of the NHS and OHE’s Nancy Devlin and Yan Feng examined…
New OHE Study Compares Decisions by Five HTA Agencies on Oncology Meds
31 January 2013
Just out in the International Journal of Technology Assessment in Health Care is an important new study that reviews appraisals of breast cancer and colorectal cancer…
Overview of the OHE Study on the Cost of Drug Development Presented
29 January 2013
OHE’s Jorge Mestre-Ferrandiz reviewed the results of OHE’s recent study on the R&D cost of developing a new drug at a seminar at University College London.…
Changes in Determining Medicines Pricing in France, Germany and the UK
24 January 2013
New requirements for health technology assessment in Europe have important implications for markets and for access to new medicines. At a recent conference, OHE’s Jorge Mestre-Ferrandiz…
Join OHE on Twitter, LinkedIn and SlideShare
21 January 2013
Keeping up with the latest important information is a constant challenge — made both easier and more difficult by the explosion in communication avenues. To ensure…
R&D Cost Drivers to be Explained by OHE Expert
18 January 2013
Jorge Mestre-Ferrandiz, lead author on OHE’s recent report on the cost of developing new drugs, will be discussing the important cost drivers at an upcoming UCL…